Abiomed, Inc. has disabled several remote monitoring features within the Impella Connect software portal, which is a web-based platform used by medical staff to view heart pump data remotely. This action affects software versions 1.1 through 3.17.1. The features were removed because they have not been evaluated by the FDA for safety and effectiveness, meaning their reliability for patient care has not been officially confirmed. The disabled features include email notifications, specific alarm color coding on the software dashboard, the ability to sort patients by alarm color, and certain pump metric displays.
Relying on software features that have not been evaluated for safety and effectiveness could lead to clinicians missing critical alerts or misinterpreting the status of a patient's heart pump. This may result in delayed medical intervention or incorrect treatment decisions for patients being monitored remotely.
Manufacturer disabled specific software features that lacked FDA evaluation.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.